Alaunos Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MSD PARTNERS, L.P. | 08/14/2024 | 1.01 M | $706.06 K | 0.00% | 6.31% |
VANGUARD GROUP INC | 08/13/2024 | 629.15 K | $439.78 K | 0.00% | 3.93% |
BLACKROCK INC. | 08/13/2024 | 222.44 K | $155.49 K | 0.00% | 1.39% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 163.59 K | $114.37 K | 8.76% | 1.02% |
UBS GROUP AG | 08/14/2024 | 54.85 K | $38.34 K | 238.78% | 0.34% |
STATE STREET CORP | 08/14/2024 | 50.21 K | $35.09 K | -0.25% | 0.31% |
CITADEL ADVISORS LLC | 08/14/2024 | 43.09 K | $30.12 K | 18.79% | 0.27% |
COMMERCE BANK | 08/12/2024 | 29.13 K | $20.36 K | 0.00% | 0.18% |
ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 24.29 K | $16.99 K | -27.76% | 0.15% |
MAGNOLIA CAPITAL ADVISORS LLC | 08/15/2024 | 20.61 K | $14.40 K | -16.55% | 0.13% |
CITADEL ADVISORS LLC | 08/14/2024 | 16.91 K | $11.82 K | 100.00% | 0.11% |
ALLRED CAPITAL MANAGEMENT, LLC | 08/13/2024 | 16.87 K | $11.79 K | 0.00% | 0.11% |
PFG INVESTMENTS, LLC | 08/07/2024 | 16.17 K | $11.30 K | 100.00% | 0.10% |
MORGAN STANLEY | 10/17/2024 | 14.94 K | $10.44 K | -12.61% | 0.09% |
CIBC PRIVATE WEALTH GROUP, LLC | 08/09/2024 | 14.67 K | $9.35 K | 0.00% | 0.09% |
FORTIS GROUP ADVISORS, LLC | 07/30/2024 | 14.00 K | $9.79 K | 0.00% | 0.09% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 12.71 K | $8.88 K | -2.19% | 0.08% |
GROUP ONE TRADING, L.P. | 08/14/2024 | 12.70 K | $8.88 K | -5.50% | 0.08% |
09/05/2024 | 12.30 K | $16.24 K | 100.00% | 0.08% | |
ATRIA WEALTH SOLUTIONS, INC. | 07/22/2024 | 11.15 K | $7.79 K | 0.00% | 0.07% |
HRT FINANCIAL LP | 08/12/2024 | 10.48 K | $7.00 K | 100.00% | 0.07% |
TWO SIGMA SECURITIES, LLC | 08/14/2024 | 10.23 K | $7.15 K | 100.00% | 0.06% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 7.55 K | $5.28 K | 133.55% | 0.05% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2024 | 5.25 K | $3.67 K | -47.06% | 0.03% |
SUGARLOAF WEALTH MANAGEMENT, LLC | 07/08/2024 | 4.37 K | $3.05 K | 0.00% | 0.03% |
BNP PARIBAS ARBITRAGE, SNC | 08/13/2024 | 3.46 K | $2.42 K | 0.00% | 0.02% |
CITADEL ADVISORS LLC | 08/14/2024 | 3.25 K | $2.27 K | 625.00% | 0.02% |
ADVISORNET FINANCIAL, INC | 07/16/2024 | 2.82 K | $1.97 K | 0.00% | 0.02% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/08/2024 | 1.91 K | $1.34 K | -17.32% | 0.01% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 1.66 K | $1.16 K | 7.60% | 0.01% |
ASSET DEDICATION, LLC | 08/06/2024 | 550 | $385 | 100.00% | 0.00% |
RHUMBLINE ADVISERS | 08/01/2024 | 391 | $273 | -7.78% | 0.00% |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 09/11/2024 | 252 | $176 | 0.00% | 0.00% |
KEY FINANCIAL INC | 07/30/2024 | 245 | $171 | 0.00% | 0.00% |
SIGNATUREFD, LLC | 07/29/2024 | 233 | $163 | 0.00% | 0.00% |
REDWOOD WEALTH MANAGEMENT GROUP, LLC | 08/09/2024 | 200 | $140 | 100.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/16/2024 | 166 | $116 | 100.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 105 | $73 | 0.00% | 0.00% |
WEST PACES ADVISORS INC. | 07/17/2024 | 100 | $70 | 0.00% | 0.00% |
PFS PARTNERS, LLC | 07/25/2024 | 66 | $47 | 0.00% | 0.00% |
PSI ADVISORS, LLC | 07/23/2024 | 66 | $46 | 0.00% | 0.00% |
TIDEMARK, LLC | 08/12/2024 | 26 | $18 | 0.00% | 0.00% |
TUCKER ASSET MANAGEMENT LLC | 08/09/2024 | 13 | $9 | 0.00% | 0.00% |
TRUST CO OF VERMONT | 07/09/2024 | 6 | $4 | 100.00% | 0.00% |
CENTRAL TRUST CO | 08/05/2024 | 0 | $0 | -100.00% | 0.00% |
NBC SECURITIES, INC. | 07/10/2024 | 0 | $0 | -100.00% | 0.00% |
HARBOUR INVESTMENTS, INC. | 07/26/2024 | 0 | $0 | -100.00% | 0.00% |
HARBOR INVESTMENT ADVISORY, LLC | 07/19/2024 | 0 | $0 | -100.00% | 0.00% |
SIMPLEX TRADING, LLC | 07/25/2024 | 0 | $0 | -100.00% | 0.00% |
VIRTU FINANCIAL LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
Alaunos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 64 institutional investors and hedge funds held shares of Alaunos Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 222,440
Cetera Advisor Networks LLC: 0
Simplicity Solutions, LLC: 14,250
GAMBLE JONES INVESTMENT COUNSEL: 61,000
TRUSTCORE FINANCIAL SERVICES, LLC: 250
American Portfolios Advisors: 2,100
15.18% of Alaunos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.69 M shares in the last 24 months. This purchase volume represents approximately $39.02 M in transactions.